Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. 1995

P D Stein, and J S Alpert, and J Copeland, and J E Dalen, and S Goldman, and A G Turpie

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D006350 Heart Valve Prosthesis A device that substitutes for a heart valve. It may be composed of biological material (BIOPROSTHESIS) and/or synthetic material. Prosthesis, Heart Valve,Cardiac Valve Prosthesis,Cardiac Valve Prostheses,Heart Valve Prostheses,Prostheses, Cardiac Valve,Prostheses, Heart Valve,Prosthesis, Cardiac Valve,Valve Prostheses, Cardiac,Valve Prostheses, Heart,Valve Prosthesis, Cardiac,Valve Prosthesis, Heart
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect

Related Publications

P D Stein, and J S Alpert, and J Copeland, and J E Dalen, and S Goldman, and A G Turpie
November 1996, Circulation,
P D Stein, and J S Alpert, and J Copeland, and J E Dalen, and S Goldman, and A G Turpie
March 2009, The Libyan journal of medicine,
P D Stein, and J S Alpert, and J Copeland, and J E Dalen, and S Goldman, and A G Turpie
January 2010, Kardiologiia,
P D Stein, and J S Alpert, and J Copeland, and J E Dalen, and S Goldman, and A G Turpie
February 1986, Chest,
P D Stein, and J S Alpert, and J Copeland, and J E Dalen, and S Goldman, and A G Turpie
February 1989, Chest,
P D Stein, and J S Alpert, and J Copeland, and J E Dalen, and S Goldman, and A G Turpie
December 1986, Journal of the American College of Cardiology,
P D Stein, and J S Alpert, and J Copeland, and J E Dalen, and S Goldman, and A G Turpie
January 1998, Pharmacotherapy,
P D Stein, and J S Alpert, and J Copeland, and J E Dalen, and S Goldman, and A G Turpie
January 2018, Cardiology in review,
P D Stein, and J S Alpert, and J Copeland, and J E Dalen, and S Goldman, and A G Turpie
March 1995, The Journal of heart valve disease,
P D Stein, and J S Alpert, and J Copeland, and J E Dalen, and S Goldman, and A G Turpie
January 2016, Mediators of inflammation,
Copied contents to your clipboard!